首页 | 本学科首页   官方微博 | 高级检索  
     

蛋白酪氨酸磷酸酶-1B抑制剂研究进展
引用本文:刘霞,冯长根. 蛋白酪氨酸磷酸酶-1B抑制剂研究进展[J]. 科技导报(北京), 2012, 30(10): 72-79. DOI: 10.3981/j.issn.1000-7857.2012.10.011
作者姓名:刘霞  冯长根
作者单位:1. 中国农业大学理学院,北京 100193;2. 北京理工大学机电学院,北京 100081
摘    要: 蛋白酪氨酸磷酸酶-1B(PTP-1B)在胰岛素信号转导中起负调节作用,是治疗2型糖尿病和肥胖症的一个新靶点。PTP-1B抑制剂可有效治疗2型糖尿病和肥胖症。本文综述了近年来PTP-1B抑制剂的研究进展,重点归纳了通过化学合成方法得到了多种PTP-1B抑制剂,如钒酸盐类化合物、磷酸酯类化合物、肽类化合物等。

关 键 词:蛋白酪氨酸磷酸酶-1B  抑制剂  2型糖尿病  
收稿时间:2012-02-23

Research Progress on Inhibitors of Protein Tyrosine Phosphatase-1B
LIU Xia,FENG Changgen. Research Progress on Inhibitors of Protein Tyrosine Phosphatase-1B[J]. Science & Technology Review, 2012, 30(10): 72-79. DOI: 10.3981/j.issn.1000-7857.2012.10.011
Authors:LIU Xia  FENG Changgen
Affiliation:1. College of Science, China Agricultural University, Beijing 100193, China;2. School of Mechatronical Engineering, Beijing Institute of Technology, Beijing 100081, China
Abstract:Protein-tyrosine phosphatase-1B acts as a negative regulator of the insulin signal transduction, serving as a new therapeutic target in type 2 diabetes and obesity. Inhibitors of PTP-1B may be beneficial in the treatment of type 2 diabetes and obesity. This paper reviews recent progresses of researches on inhibitors of PTP-1B, with PTP-1B inhibitors obtained by chemical synthesis being summarized, including vanadate compounds, phosphate compounds, peptide compounds and others.
Keywords:PTP-1B  inhibitors  type 2 diabetes  
点击此处可从《科技导报(北京)》浏览原始摘要信息
点击此处可从《科技导报(北京)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号